Literature DB >> 12646415

Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

Laura Tadlock1, Yoko Yamagiwa, James Hawker, Carla Marienfeld, Tushar Patel.   

Abstract

Although the proteasome plays a critical role in the controlled degradation of proteins involved in cell cycle control, the direct modulation of proteasomal function by growth regulatory signaling has not yet been demonstrated. We assessed the effect of transforming growth factor (TGF)-beta, a potent inhibitor of cell growth, on proteasomal function. TGF-beta selectively decreased hydrolysis of the proteasomal substrate Cbz-Leu-Leu-Leu-7-amido-4-methyl-coumarin (z-LLL-AMC) in a concentration-dependent manner but did not inhibit hydrolysis of other substrates Suc-Leu-Leu-Val-Tyr-AMC (suc-LLVY-AMC) or Cbz-Leu-Leu-Glu-AMC (z-LLE-AMC). An increase in intracellular oxidative injury occurred during incubation with TGF-beta. Furthermore, in vitro hydrolysis of z-LLL-AMC, but not suc-LLVY-AMC, was decreased by hydrogen peroxide. TGF-beta did not increase cellular expression of heat shock protein (HSP)90, a potent inhibitor of z-LLL-AMC hydrolysis in vitro. The physiological relevance of TGF-beta inhibition of proteasomal activity was studied by assessing the role of z-LLL-AMC hydrolysis on cyclin-dependent kinase inhibitor expression and cell growth. TGF-beta increased expression of p27KIP1 but did not alter expression of p21WAF1 or p16INK4A. The peptide aldehyde Cbz-Leu-Leu-leucinal (LLL-CHO or MG132) potently inhibited z-LLL-AMC hydrolysis in cell extracts as well as increasing p27KIP1 and decreasing cell proliferation. Thus growth inhibition by TGF-beta decreases a specific proteasomal activity via an HSP90-independent mechanism that may involve oxidative inactivation or modulation of proteasomal subunit composition and results in altered cellular expression of key cell cycle regulatory proteins such as p27KIP1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646415     DOI: 10.1152/ajpcell.00550.2002

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  9 in total

1.  Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.

Authors:  Peter J Naus; Roger Henson; Grant Bleeker; Hania Wehbe; Fanyin Meng; Tushar Patel
Journal:  J Hepatol       Date:  2006-10-06       Impact factor: 25.083

Review 2.  Autocrine regulation of biliary pathology by activated cholangiocytes.

Authors:  Kendal Jensen; Marco Marzioni; Kamruzzaman Munshi; Syeda Afroze; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

3.  Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.

Authors:  Molly Lang; Roger Henson; Chiara Braconi; Tushar Patel
Journal:  Liver Int       Date:  2009-02-17       Impact factor: 5.828

4.  Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Authors:  Fanyin Meng; Yoko Yamagiwa; Yoshiyuki Ueno; Tushar Patel
Journal:  J Hepatol       Date:  2005-12-13       Impact factor: 25.083

5.  Transforming growth factor B1 stimulated DNA synthesis in the granulosa cells of preantral follicles: negative interaction with epidermal growth factor.

Authors:  Peixin Yang; Shyamal K Roy
Journal:  Biol Reprod       Date:  2006-03-08       Impact factor: 4.285

Review 6.  Genetic and molecular abnormalities in cholangiocarcinogenesis.

Authors:  Victor J Hassid; Frank A Orlando; Ziad T Awad; Dongfeng Tan; Thaer Khoury; Bestoun H Ahmed; Sadir J Alrawi
Journal:  Anticancer Res       Date:  2009-04       Impact factor: 2.480

7.  TGFβ1 Induces Axonal Outgrowth via ALK5/PKA/SMURF1-Mediated Degradation of RhoA and Stabilization of PAR6.

Authors:  Julia Kaiser; Martina Maibach; Ester Piovesana; Iris Salpeter; Nora Escher; Yannick Ormen; Martin E Schwab
Journal:  eNeuro       Date:  2020-09-29

Review 8.  Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2.

Authors:  Ioannis A Voutsadakis
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

9.  USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway.

Authors:  Tao Zhang; Goran Periz; Yu-Ning Lu; Jiou Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.